Company record · MCK · Wholesale-Drugs, Proprietaries & Druggists' Sundries
McKesson Corporation
The principal financial officer who signed McKesson Corporation's latest annual report, the 10-K filed May 8, 2026, is Britt J. Vitalone.
The record holds the CFO signature on McKesson Corporation's 10-K filed May 8, 2026 and no Form 8-K CFO change.
The CFO seat
Computed from the records below: a move filed on or after the 10-K replaces the 10-K's signature.
| Status | Filled |
|---|---|
| Officer | Britt J. Vitalone |
| Title as printed | Executive Vice President and Chief Financial Officer (Principal Financial Officer) |
| Basis | Verified May 8, 2026: the 10-K signature block (sec.gov) |
Seat timeline
1Every verified record for this seat, newest first, dated as the filing states it.
2026-05-0810-K signature
Britt J. Vitalone signed the annual report as Executive Vice President and Chief Financial Officer (Principal Financial Officer)
10-K filed May 8, 2026 · sec.gov
“/s/ Britt J. Vitalone /s/ James H. Hinton Britt J. Vitalone Executive Vice President and Chief Financial Officer (Principal Financial Officer)”
Company
| Ticker | MCK |
|---|---|
| SEC CIK | 0000927653 |
| Industry (SIC) | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) |
| Roster note | The DEF 14A filed 2026-06-12 also names Britt J. Vitalone alongside a Chief Financial Officer title. An 8-K with Item 5.02 was filed on 2026-07-01, after this 10-K; any CFO change it reports is tracked on the moves record. |
Same industry on the record
3Other companies the roster files under SIC “Wholesale-Drugs, Proprietaries & Druggists' Sundries”.
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.